Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 6.53% is 12% below its 5-year average of 7.42%, near the low end of its 5-year range (3.49%–48.20%).
As of the fiscal period ended Tuesday, June 30, 2026. 71.74% below its 12-month average of 23.13%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.53%.
DEBT TO ASSETS RATIO
6.53%
DEBT TO ASSETS RATIO AVG TTM
23.13%
DEBT TO ASSETS RATIO AVG 3Y
9.22%
DEBT TO ASSETS RATIO AVG 5Y
7.42%
DEBT TO ASSETS RATIO AVG 10Y
7.67%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-71.74%
CURRENT VS 3Y AVG
-29.10%
CURRENT VS 5Y AVG
-11.97%
CURRENT VS 10Y AVG
-14.79%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 866 covered companies
CURRENT VS SECTOR MEDIAN
+7160.77%
vs the sector median at left
Editas Medicine, Inc.
Market Cap
$428.93M
Debt to Assets Ratio
6.53%
TTM Avg
23.13%
3Y Avg
9.22%
5Y Avg
7.42%
Market Cap
$433.61M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$434.39M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$425.52M
Debt to Assets Ratio
0.17%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$422.54M
Debt to Assets Ratio
0.69%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$421.18M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$443.12M
Debt to Assets Ratio
0.25%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$415.64M
Debt to Assets Ratio
0.35%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Editas Medicine, Inc. (EDIT) | $428.93M | 6.53% | 23.13% | 9.22% | 7.42% |
| NeoGenomics, Inc. (NEO)vs › | $428.80M | 0.33% | N/A | N/A | N/A |
| Tectonic Therapeutic, Inc. (TECX)vs › | $433.61M | 0.02% | N/A | N/A | N/A |
| Assembly Biosciences, Inc. (ASMB)vs › | $434.39M | 0.01% | N/A | N/A | N/A |
| Tilray Brands, Inc. (TLRY)vs › | $425.52M | 0.17% | N/A | N/A | N/A |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $422.54M | 0.69% | N/A | N/A | N/A |
| Prothena Corporation plc (PRTA)vs › | $421.18M | 0.02% | N/A | N/A | N/A |
| Capricor Therapeutics, Inc. (CAPR)vs › | $443.12M | 0.25% | N/A | N/A | N/A |
| Senseonics Holdings, Inc. (SENS)vs › | $415.64M | 0.35% | N/A | N/A | N/A |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $445.33M | 0.00% | N/A | N/A | N/A |
Debt/Assets
6.5%
Debt/Equity
0.15
Current Ratio
3.19
Interest Coverage
-16.1x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 6.53% |
| 2026-03-31 | 48.20% |
| 2025-12-31 | 41.12% |
| 2025-09-30 | 9.74% |
| 2025-06-30 | 10.04% |
| 2025-03-31 | 11.81% |
| 2024-12-31 | 10.26% |
| 2024-09-30 | 11.75% |
| 2024-06-30 | 10.06% |
| 2024-03-31 | 7.75% |
| 2023-12-31 | 9.72% |
| 2023-09-30 | 6.86% |
| 2023-06-30 | 6.86% |
| 2023-03-31 | 8.00% |
| 2022-12-31 | 8.54% |
| 2022-09-30 | 4.01% |
| 2022-06-30 | 3.49% |
| 2022-03-31 | 3.72% |
| 2021-12-31 | 3.89% |
| 2021-09-30 | 4.00% |
| 2021-06-30 | 4.00% |
| 2021-03-31 | 3.70% |
| 2020-12-31 | 4.56% |
| 2020-09-30 | 4.47% |
| 2020-06-30 | 4.39% |
| 2020-03-31 | 5.82% |
| 2019-12-31 | 5.71% |
| 2019-09-30 | 4.74% |
| 2019-06-30 | 4.90% |
| 2019-03-31 | 4.85% |
| 2018-12-31 | 7.71% |
| 2018-09-30 | 8.43% |
| 2018-06-30 | 8.37% |
| 2018-03-31 | 8.22% |
| 2017-12-31 | 8.96% |
| 2017-09-30 | 9.93% |
| 2017-06-30 | 13.25% |
| 2017-03-31 | 12.39% |
| 2016-12-31 | 15.31% |
| 2016-09-30 | 13.23% |
| 2016-06-30 | 9.08% |
| 2016-03-31 | 4.68% |
| 2015-12-31 | 133.85% |
| 2015-09-30 | 1.14% |
| 2015-06-30 | 2.36% |
| 2014-12-31 | 3.37% |
